PropertyValue
?:abstract
  • Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug-drug interactions (DDIs).
is ?:annotates of
?:creator
?:journal
  • SN_Compr_Clin_Med
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate
?:type
?:who_covidence_id
  • #953840
?:year
  • 2020

Metadata

Anon_0  
expand all